Status:
COMPLETED
Non-interventional Study to Evaluate the Ease of Reaching Individual Goals in Serum Phosphorus (Steering)
Lead Sponsor:
Fresenius Medical Care Deutschland GmbH
Collaborating Sponsors:
Siro Clinpharm Germany GmbH
Conditions:
Hyperphosphataemia
ESRD
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this non-interventional study is to confirm that with standard OsvaRen® treatment it is possible to achieve in at least 60% of the patients the levels of phosphorus, total calcium, an...
Detailed Description
Only a small fraction of haemodialysis patients meet the published NKF-KDOQI standards for calcium, phosphorus, calcium x phosphorus product and intact parathyroid hormone. One of the reasons is the s...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Signed Informed Consent
- Patient on maintenance haemodialysis, online haemodiafiltration, or peritoneal dialysis at the time of OsvaRen® prescription
- Patients being treated with OsvaRen® for up to 6 months at the day of inclusion
Exclusion
- Prior participation in this observational study
- Use of OsvaRen® for purposes other than those indicated in the Summary of Product Characteristics (SmPC) / package leaflet
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
324 Patients enrolled
Trial Details
Trial ID
NCT01424787
Start Date
October 1 2011
End Date
March 1 2014
Last Update
March 6 2015
Active Locations (24)
Enter a location and click search to find clinical trials sorted by distance.
1
Regionshospitalet Holstebro
Holstebro, Holstebro, Denmark, 7500
2
Nykøbing Falster Sygehus
Nykøbing Mors, Nykobing, Denmark, 4800
3
Roskilde Sygehus
Roskilde, Roskilde, Denmark, 4000
4
Viborg Sygehus
Viborg, Viborg, Denmark, 8800